Ildstad S T, Bluestone J A, Sachs D H
J Exp Med. 1986 May 1;163(5):1343-8. doi: 10.1084/jem.163.5.1343.
In the mixed allogeneic reconstitution (B10 + B10.D2----B10) model, alloresistance to engraftment of allogeneic donor results if the syngeneic component of the mixed bone marrow inoculum is not depleted of Lyt-2+ cells before transplantation. Resultant experimental animals repopulate as fully syngeneic, reject B10.D2 skin allografts, and are reactive to B10.D2 lymphoid cells in vitro, as assessed by mixed lymphocyte culture proliferative and cellular cytotoxicity assays. In contrast, depletion of Lyt-2-reactive cells from the syngeneic component of the mixed bone marrow inoculum results in mixed lymphopoietic chimerism and specific in vivo transplantation tolerance to B10.D2 allogeneic donor skin grafts and in vitro unreactivity to B10.D2 lymphoid elements. Full reactivity to third party is evident both in vitro and in vivo in these animals. This model may be helpful in further study of the syngeneic host-type cell phenotypes responsible for alloresistance to bone marrow engraftment.
在混合异体重建(B10 + B10.D2----B10)模型中,如果混合骨髓接种物的同基因成分在移植前未清除Lyt-2+细胞,就会出现对异基因供体植入的同种异体抗性。由此产生的实验动物会以完全同基因的方式重新填充,排斥B10.D2皮肤异体移植,并且通过混合淋巴细胞培养增殖和细胞毒性试验评估,在体外对B10.D2淋巴细胞有反应。相反,从混合骨髓接种物的同基因成分中清除Lyt-2反应性细胞会导致混合淋巴细胞嵌合体以及对B10.D2异基因供体皮肤移植的特异性体内移植耐受性,并且在体外对B10.D2淋巴细胞成分无反应。在这些动物中,对第三方的完全反应性在体外和体内都很明显。该模型可能有助于进一步研究负责对骨髓植入产生同种异体抗性的同基因宿主型细胞表型。